Lexaria Bioscience Corp.
LEXX
$1.35
-$0.34-20.12%
NASDAQ
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 36.50% | 300.58% | 343.64% | 147.72% | 35.41% |
| Total Receivables | -7.25% | -50.72% | 21.94% | 20.95% | 161.04% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 218.74% | 235.68% | 117.23% | -39.73% | -16.52% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 42.60% | 227.65% | 267.14% | 114.69% | 35.30% |
|
|
|||||
| Total Current Assets | 42.60% | 227.65% | 267.14% | 114.69% | 35.30% |
| Net Property, Plant & Equipment | 1.78% | 2.15% | -7.59% | -20.31% | 12.83% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -2.52% | 2.22% | 11.69% | -9.14% | 0.31% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 62.03% | 31.69% | 30.86% | -- | -- |
| Total Assets | 36.61% | 170.04% | 187.54% | 91.21% | 30.83% |
|
|
|||||
| Total Accounts Payable | 2,580.71% | 184.58% | 68.84% | -87.85% | -71.57% |
| Total Accrued Expenses | 6,580.52% | 1.47% | 4,507.38% | -70.47% | -65.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.98% | 12.50% | 0.72% | -15.48% | -9.28% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 2,130.60% | 139.20% | 310.68% | -85.23% | -63.38% |
|
|
|||||
| Total Current Liabilities | 2,130.60% | 139.20% | 310.68% | -85.23% | -63.38% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -22.94% | -21.31% | -19.75% | -19.14% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 838.69% | 57.36% | 199.26% | -77.36% | -8.47% |
|
|
|||||
| Common Stock & APIC | 18.67% | 26.40% | 22.14% | 21.67% | 14.87% |
| Retained Earnings | -19.72% | -15.59% | -12.66% | -10.89% | -12.90% |
| Treasury Stock & Other | -473.79% | -622.73% | -- | -- | -- |
| Total Common Equity | 9.57% | 161.17% | 164.00% | 130.29% | 31.10% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 9.57% | 161.17% | 164.00% | 130.29% | 31.10% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -2.98% | -2.84% | -3.65% | -6.01% | -8.94% |
| Total Equity | 9.97% | 178.53% | 185.78% | 141.20% | 32.73% |
|
|
|||||